Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban vs aspirin in non-valvular atrial fibrillation patients unsuitable for VKAs
CTR20132406Phase 3Active
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apixaban in Atrial fibrillation (AFib), sponsored by Bristol Myers Squibb. Started Oct 2015; status: active.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on CTR20132406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132406.